First evidence of overlaps between HIV-associated dementia (HAD) and non-viral neurodegenerative diseases: Proteomic analysis of the frontal cortex from HIV+ patients with and without dementia

Molecular Neurodegeneration

Volumn 5, Issue 1, 2010, Pages

  Zhou, Li ^a   Diefenbach, Eve ^a   Crossett, Ben ^a   Tran, Sieu L ^a   Ng, Thomas ^b   Rizos, Helen ^a   Rua, Rejane ^a,e   Wang, Bin ^a   Kapur, Amit ^c   Gandhi, Kaushal ^a   Brew, Bruce J ^d   Saksena, Nitin K ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c MACQUARIE UNIVERSITY   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e ECOLE NORMALE SUPÉRIEURE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; DNA; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; HEAT SHOCK COGNATE PROTEIN 70; STATHMIN;

ADULT; ALZHEIMER DISEASE; ANTIGEN PRESENTATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DNA FINGERPRINTING; ENERGY METABOLISM; FRONTAL CORTEX; FUNCTIONAL PROTEOMICS; GEL ELECTROPHORESIS; GLUCONEOGENESIS; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VALIDATION PROCESS; WESTERN BLOTTING;

EID: 77955676756     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-5-27     Document Type: Article

References (113)

1. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. LA Cysique P Maruff BJ Brew, Journal of neurovirology 2004 10 350 357 10.1080/13550280490521078 15765806
2. Planning Future Strategies for Domestic and International NeuroAIDS Research, July 24-25, 2008. J Joseph D Clifford SD Douglas H Fox HE Gendelman F Gonzalez-Scarano I Grant E Major J McArthur, J Neuroimmune Pharmacol 2009 4 283 297 10.1007/s11481-009-9159-1 19455426
3. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. GJ Dore A McDonald Y Li JM Kaldor BJ Brew, AIDS (London, England) 2003 17 1539 1545 12824792
4. The coming problem of HIV-associated Alzheimer's disease. JM Alisky, Medical hypotheses 2007 69 1140 1143 10.1016/j.mehy.2007.02.030 17433562
5. Microarray analysis of cytokine and chemokine genes in the brains of macaques with SHIV-encephalitis. Y Sui R Potula D Pinson I Adany Z Li J Day E Buch J Segebrecht F Villinger Z Liu M Huang O Narayan S Buch, Journal of medical primatology 2003 32 229 239 10.1034/j.1600-0684.2003.00030.x 14498983
6. Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays. GK Geiss RE Bumgarner MC An MB Agy AB van 't Wout E Hammersmark VS Carter D Upchurch JI Mullins MG Katze, Virology 2000 266 8 16 10.1006/viro.1999.0044 10612655
7. Differential transcriptional regulation by human immunodeficiency virus type 1 and gp120 in human astrocytes. D Galey K Becker N Haughey A Kalehua D Taub J Woodward MP Mattson A Nath, Journal of neurovirology 2003 9 358 371 12775419
8. Patterns of gene expression in peripheral blood mononuclear cells of rhesus macaques infected with SIVmac251 and exhibiting differential rates of disease progression. MT Vahey ME Nau M Taubman J Yalley-Ogunro P Silvera MG Lewis, AIDS research and human retroviruses 2003 19 369 387 10.1089/ 088922203765551728 12803996
9. Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS. ES Roberts MA Zandonatti DD Watry LJ Madden SJ Henriksen MA Taffe HS Fox, The American journal of pathology 2003 162 2041 2057 12759259
10. HIV-1 infected monocyte-derived macrophages affect the human brain microvascular endothelial cell proteome: new insights into blood-brain barrier dysfunction for HIV-1-associated dementia. M Ricardo-Dukelow I Kadiu W Rozek J Schlautman Y Persidsky P Ciborowski GD Kanmogne HE Gendelman, J Neuroimmunol 2007 185 37 46 10.1016/j.jneuroim.2007.01.004 17321604
11. Genomic and proteomic microglial profiling: pathways for neuroprotective inflammatory responses following nerve fragment clearance and activation. JG Glanzer Y Enose T Wang I Kadiu N Gong W Rozek J Liu JD Schlautman PS Ciborowski MP Thomas HE Gendelman, Journal of neurochemistry 2007 102 627 645 10.1111/j.1471-4159.2007.04568.x 17442053
12. Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment. W Rozek M Ricardo-Dukelow S Holloway HE Gendelman V Wojna LM Melendez P Ciborowski, Journal of proteome research 2007 6 4189 4199 10.1021/pr070220c 17929958
13. CSF proteomic fingerprints for HIV-associated cognitive impairment. JP Laspiur ER Anderson P Ciborowski V Wojna W Rozek F Duan R Mayo E Rodriguez M Plaud-Valentin J Rodriguez-Orengo HE Gendelman LM Melendez, J Neuroimmunol 2007 192 157 170 10.1016/j.jneuroim.2007.08.004 17950469
14. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. A Castegna M Aksenov M Aksenova V Thongboonkerd JB Klein WM Pierce R Booze WR Markesbery DA Butterfield, Free radical biology & medicine 2002 33 562 571
15. The comparative enzymology of creatine kinases. I. Isolation and characterization from chicken and rabbit tissues. HM Eppenberger DM Dawson NO Kaplan, The Journal of biological chemistry 1967 242 204 209 6016604
16. Creatine kinase in non-muscle tissues and cells. T Wallimann W Hemmer, Molecular and cellular biochemistry 1994 133-134 193 220 10.1007/BF01267955 7808454
17. The expression of creatine kinase isoenzymes in neocortex of patients with neurodegenerative disorders: Alzheimer's and Pick's disease. MY Aksenov MV Aksenova RM Payne CD Smith WR Markesbery JM Carney, Experimental neurology 1997 146 458 465 10.1006/exnr.1997.6550 9270056
18. HIV-1 Tat-mediated protein transduction of human brain creatine kinase into PC12 cells. MS Jeong DW Kim MJ Lee YP Lee SY Kim SH Lee SH Jang KS Lee J Park TC Kang SW Cho OS Kwon WS Eum SY Choi, BMB reports 2008 41 537 541 18682038
19. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. CD Smith JM Carney PE Starke-Reed CN Oliver ER Stadtman RA Floyd WR Markesbery, Proceedings of the National Academy of Sciences of the United States of America 1991 88 10540 10543 10.1073/pnas.88.23.10540 1683703
20. Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: a potential diagnostic biochemical marker. D Gunnersen B Haley, Proceedings of the National Academy of Sciences of the United States of America 1992 89 11949 11953 10.1073/pnas.89.24.11949 1361232
21. Increased glutamine synthetase immunoreactivity in experimental pneumococcal meningitis. AK Stringaris W Bruck H Tumani H Schmidt R Nau, Acta neuropathologica 1997 93 215 218 10.1007/s004010050606 9083551
22. Glutamate metabolism in HIV-infected macrophages: implications for the CNS. F Porcheray C Leone B Samah AC Rimaniol N Dereuddre-Bosquet G Gras, American journal of physiology 2006 291 618 626 10.1152/ajpcell.00021.2006 16687472
23. N-acetylcysteine prevents HIV gp 120-related damage of human cultured astrocytes: correlation with glutamine synthase dysfunction. V Visalli C Muscoli I Sacco F Sculco E Palma N Costa C Colica D Rotiroti V Mollace, BMC neuroscience 2007 8 106 10.1186/1471-2202-8-106 18062818
24. Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu. L Valente V Tiranti RM Marsano E Malfatti E Fernandez-Vizarra C Donnini P Mereghetti L De Gioia A Burlina C Castellan GP Comi S Savasta I Ferrero M Zeviani, American journal of human genetics 2007 80 44 58 10.1086/510559 17160893
25. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein. A Cimarelli J Luban, Journal of virology 1999 73 5388 5401 10364286
26. Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers. A Macho M Castedo P Marchetti JJ Aguilar D Decaudin N Zamzami PM Girard J Uriel G Kroemer, Blood 1995 86 2481 2487 7670095
27. Sustained TCR signaling is required for mitogen-activated protein kinase activation and degranulation by cytotoxic T lymphocytes. NN Berg LG Puente W Dawicki HL Ostergaard, J Immunol 1998 161 2919 2924 9743353
28. HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway. E Toschi I Bacigalupo R Strippoli C Chiozzini A Cereseto M Falchi F Nappi C Sgadari G Barillari F Mainiero B Ensoli, Molecular biology of the cell 2006 17 1985 1994 10.1091/mbc.E05-08-0717 16436505
29. Decreased protein levels of stathmin in adult brains with Down syndrome and Alzheimer's disease. MS Cheon M Fountoulakis NJ Cairns M Dierssen K Herkner G Lubec, Journal of neural transmission 2001 281 288 11771751 (Pubitemid 38085090)
30. Stathmin: a tubulin-sequestering protein which forms a ternary T2 S complex with two tubulin molecules. L Jourdain P Curmi A Sobel D Pantaloni MF Carlier, Biochemistry 1997 36 10817 10821 10.1021/bi971491b 9312271
31. Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules. LD Belmont TJ Mitchison, Cell 1996 84 623 631 10.1016/S0092-8674(00)81037-5 8598048
32. Regulation and subcellular localization of the microtubule-destabilizing stathmin family phosphoproteins in cortical neurons. O Gavet S El Messari S Ozon A Sobel, Journal of neuroscience research 2002 68 535 550 10.1002/jnr.10234 12111843
33. Microtubule dynamics and tubulin interacting proteins. CE Walczak, Current opinion in cell biology 2000 12 52 56 10.1016/S0955-0674(99)00056-3 10679354
34. Requirement for microtubule integrity in the SOCS1-mediated intracellular dynamics of HIV-1 Gag. M Nishi A Ryo N Tsurutani K Ohba T Sawasaki R Morishita K Perrem I Aoki Y Morikawa N Yamamoto, FEBS letters 2009 583 1243 1250 10.1016/j.febslet.2009.03.041 19327355
35. The GRB2/Sem-5 adaptor protein. J Downward, FEBS letters 1994 338 113 117 10.1016/0014-5793(94)80346-3 8307166
36. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. H Aktas H Cai GM Cooper, Molecular and cellular biology 1997 17 3850 3857 9199319
37. Ras1 and a putative guanine nucleotide exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase. MA Simon DD Bowtell GS Dodson TR Laverty GM Rubin, Cell 1991 67 701 716 10.1016/0092-8674(91)90065- 7 1934068
38. Amyloid precursor protein and Presenilin1 interact with the adaptor GRB2 and modulate ERK 1,2 signaling. M Nizzari V Venezia E Repetto V Caorsi R Magrassi MC Gagliani P Carlo T Florio G Schettini C Tacchetti T Russo A Diaspro C Russo, The Journal of biological chemistry 2007 282 13833 13844 10.1074/jbc.M610146200 17314098
39. Grb3-3 is up-regulated in HIV-1-infected T-cells and can potentiate cell activation through NFATc. X Li MC Multon Y Henin F Schweighoffer C Venot J Josef C Zhou J LaVecchio P Stuckert M Raab A Mhashilkar B Tocque WA Marasco, The Journal of biological chemistry 2000 275 30925 30933 10.1074/jbc.M005535200 10906142
40. Upregulation of the apoptosis-associated protein Grb3-3 in HIV-1-infected human CD4(+) lymphocytes. X Li MC Multon Y Henin F Schweighoffer C Venot J LaVecchio J Josef P Stuckert A Mhashilkar B Tocque WA Marasco, Biochemical and biophysical research communications 2000 276 362 370 10.1006/bbrc.2000.3415 11006130
41. Intracellular signalling pathways induced by chemokines in natural killer cells. AA Maghazachi, Cellular signalling 1999 11 385 390 10.1016/S0898- 6568(99)00008-X 10400311
42. Differential coupling of CC chemokine receptors to multiple heterotrimeric G proteins in human interleukin-2-activated natural killer cells. A al-Aoukaty TJ Schall AA Maghazachi, Blood 1996 87 4255 4260 8639784
43. Identification of a new Pyk2 isoform implicated in chemokine and antigen receptor signaling. I Dikic I Dikic J Schlessinger, The Journal of biological chemistry 1998 273 14301 14308 10.1074/jbc.273.23.14301 9603937
44. Beta-chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK. RK Ganju P Dutt L Wu W Newman H Avraham S Avraham JE Groopman, Blood 1998 91 791 797 9446638
45. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o). I Nishimoto T Okamoto Y Matsuura S Takahashi T Okamoto Y Murayama E Ogata, Nature 1993 362 75 79 10.1038/362075a0 8446172
46. Regulation of brain G-protein go by Alzheimer's disease gene presenilin-1. A Smine X Xu K Nishiyama T Katada P Gambetti SP Yadav X Wu YC Shi S Yasuhara V Homburger T Okamoto, The Journal of biological chemistry 1998 273 16281 16288 10.1074/jbc.273.26.16281 9632688
47. Neurotransmitters, signal transduction and second-messengers in Alzheimer's disease. RF Cowburn CJ Fowler C O'Neill, Acta neurologica Scandinavica 1996 165 25 32 (Pubitemid 26143164)
48. Interferon-inducible protein-10 and lymphotactin induce the chemotaxis and mobilization of intracellular calcium in natural killer cells through pertussis toxin-sensitive and -insensitive heterotrimeric G-proteins. AA Maghazachi BS Skalhegg B Rolstad A Al-Aoukaty, Faseb J 1997 11 765 774 9271361
49. G protein betagamma complex-mediated apoptosis by familial Alzheimer's disease mutant of APP. U Giambarella T Yamatsuji T Okamoto T Matsui T Ikezu Y Murayama MA Levine A Katz N Gautam I Nishimoto, The EMBO journal 1997 16 4897 4907 10.1093/emboj/16.16.4897 9305632
50. Neurocalcin. Role in neuronal signaling. S Vijay-Kumar VD Kumar, Methods in molecular biology (Clifton, NJ) 2002 172 261 279
51. Differential distribution of neurocalcin isoforms in rat spinal cord, dorsal root ganglia and muscle spindle. K Okazaki S Iino S Inoue S Kobayashi H Hidaka, Biochimica et biophysica acta 1994 1223 311 317 7918664
52. Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease. LC Stanley RE Mrak RC Woody LJ Perrot S Zhang DR Marshak SJ Nelson WS Griffin, Journal of neuropathology and experimental neurology 1994 53 231 238 10.1097/00005072-199405000-00003 8176406
53. Changes of neurocalcin, a calcium-binding protein, in the brain of patients with Alzheimer's disease. S Shimohama M Chachin T Taniguchi H Hidaka J Kimura, Brain Res 1996 716 233 236 10.1016/0006-8993(96)00070-4 8738246
54. Brain site-specific gene expression analysis in Alzheimer's disease patients. T Yokota M Mishra H Akatsu Y Tani T Miyauchi T Yamamoto K Kosaka Y Nagai T Sawada K Heese, European journal of clinical investigation 2006 36 820 830 10.1111/j.1365-2362.2006.01722.x 17032350
55. Modulation of stress protein (hsp27 and hsp70) expression in CD4+ lymphocytic cells following acute infection with human immunodeficiency virus type-1. Z Wainberg M Oliveira S Lerner Y Tao BG Brenner, Virology 1997 233 364 373 10.1006/viro.1997.8618 9217059
56. Stress proteins as biomarkers of oxidative stress: effects of antioxidant supplements. J Peng GL Jones K Watson, Free radical biology & medicine 2000 28 1598 1606
57. Proteomics analysis of human astrocytes expressing the HIV protein Tat. CB Pocernich D Boyd-Kimball HF Poon V Thongboonkerd BC Lynn JB Klein V Calebrese A Nath DA Butterfield, Brain research 2005 133 307 316 10.1016/j.molbrainres. 2004.10.023 15710248
58. Proteasome inhibitors induce the association of Alzheimer's amyloid precursor protein with Hsc73. Z Kouchi H Sorimachi K Suzuki S Ishiura, Biochemical and biophysical research communications 1999 254 804 810 10.1006/bbrc.1998.9977 9920821
59. Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease. BC Yoo SH Kim N Cairns M Fountoulakis G Lubec, Biochemical and biophysical research communications 2001 280 249 258 10.1006/bbrc.2000.4109 11162507 (Pubitemid 32917504)
60. Glycosylation changes in Alzheimer's disease as revealed by a proteomic approach. K Kanninen G Goldsteins S Auriola I Alafuzoff J Koistinaho, Neuroscience letters 2004 367 235 240 10.1016/j.neulet.2004.06.013 15331161
61. Transcriptional profiles in CD8+ T cells from HIV+ progressors on HAART are characterized by coordinated up-regulation of oxidative phosphorylation enzymes and interferon responses. JQ Wu DE Dwyer WB Dyer YH Yang B Wang NK Saksena, Virology 2008 380 124 135 10.1016/j.virol.2008.06.039 18692859
62. The role Acyl-CoA thioesterases play in mediating intracellular lipid metabolism. MC Hunt SE Alexson, Progress in lipid research 2002 41 99 130 10.1016/S0163-7827(01)00017-0 11755680
63. Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family. DG Mashek KE Bornfeldt RA Coleman J Berger DA Bernlohr P Black CC DiRusso SA Farber W Guo N Hashimoto V Khodiyar FA Kuypers LJ Maltais DW Nebert A Renieri JE Schaffer A Stahl PA Watkins V Vasiliou TT Yamamoto, Journal of lipid research 2004 45 1958 1961 10.1194/jlr.E400002-JLR200 15292367
64. A novel acyl-CoA thioesterase enhances its enzymatic activity by direct binding with HIV Nef. H Watanabe T Shiratori H Shoji S Miyatake Y Okazaki K Ikuta T Sato T Saito, Biochemical and biophysical research communications 1997 238 234 239 10.1006/bbrc.1997.7217 9299485
65. Binding of HIV-1 Nef to a novel thioesterase enzyme correlates with Nef-mediated CD4 down-regulation. LX Liu F Margottin S Le Gall O Schwartz L Selig R Benarous S Benichou, The Journal of biological chemistry 1997 272 13779 13785 10.1074/jbc.272.21.13779 9153233
66. Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function. M Periquet O Corti S Jacquier A Brice, Journal of neurochemistry 2005 95 1259 1276 10.1111/j.1471-4159.2005.03442.x 16150055
67. SNAPs, a family of NSF attachment proteins involved in intracellular membrane fusion in animals and yeast. DO Clary IC Griff JE Rothman, Cell 1990 61 709 721 10.1016/0092-8674(90)90482-T 2111733
68. The N-ethylmaleimide-sensitive fusion protein (NSF) is preferentially expressed in the nervous system. AW Puschel V O'Connor H Betz, FEBS letters 1994 347 55 58 10.1016/0014-5793(94)00505-2 8013662
69. A possible docking and fusion particle for synaptic transmission. G Schiavo MJ Gmachl G Stenbeck TH Sollner JE Rothman, Nature 1995 378 733 736 10.1038/378733a0 7501022
70. A novel class of fusion polypeptides inhibits exocytosis. K Matsushita CN Morrell CJ Lowenstein, Molecular pharmacology 2005 67 1137 1144 10.1124/mol.104.004275 15608145
71. Endosomal trafficking of HIV-1 gag and genomic RNAs regulates viral egress. D Molle C Segura-Morales G Camus C Berlioz-Torrent J Kjems E Basyuk E Bertrand, The Journal of biological chemistry 2009 284 19727 19743 10.1074/jbc.M109.019844 19451649
72. Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin I in brain of patients with Down syndrome and Alzheimer's disease. BC Yoo N Cairns M Fountoulakis G Lubec, Dementia and geriatric cognitive disorders 2001 12 219 225 10.1159/000051261 11244216
73. VDAC regulation by the Bcl-2 family of proteins. Y Tsujimoto S Shimizu, Cell death and differentiation 2000 7 1174 1181 10.1038/sj.cdd.4400780 11175254
74. Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome. BC Yoo M Fountoulakis N Cairns G Lubec, Electrophoresis 2001 22 172 179 10.1002/1522-2683(200101)22:1<172::AID-ELPS172>3.0.CO;2-P 11197169
75. The Bcl-2 protein family: arbiters of cell survival. JM Adams S Cory, Science (New York, NY) 1998 281 1322 1326
76. Regulation of metabolite flux through voltage-gating of VDAC channels. T Hodge M Colombini, The Journal of membrane biology 1997 157 271 279 10.1007/s002329900235 9178614
77. Regulation of mitochondrial respiration by controlling the permeability of the outer membrane through the mitochondrial channel, VDAC. MY Liu M Colombini, Biochimica et biophysica acta 1992 1098 255 260 10.1016/S0005- 2728(05)80344-5 1730010
78. Localisation of two candidate genes for mental retardation using a YAC physical map of the Xq21.1-21.2 subbands. L Colleaux M May J Belougne D Lepaslier C Schwartz M Fontes, Journal of medical genetics 1996 33 353 357 10.1136/jmg.33.5.353 8733041
79. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease. S Greber G Lubec N Cairns M Fountoulakis, Electrophoresis 1999 20 928 934 10.1002/(SICI)1522-2683(19990101) 20:4/5<928::AID-ELPS928>3.0.CO;2-Z 10344268 (Pubitemid 29222451)
80. Differential display reveals deteriorated mRNA levels of NADH3 (complex I) in cerebellum of patients with Down syndrome. K Krapfenbauer BC Yoo N Cairns G Lubec, Journal of neural transmission 1999 57 211 220 10666677
81. Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology. Z Nagy MM Esiri M LeGris PM Matthews, Acta neuropathologica 1999 97 346 354 10.1007/s004010050997 10208273
82. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. E Jacotot L Ravagnan M Loeffler KF Ferri HL Vieira N Zamzami P Costantini S Druillennec J Hoebeke JP Briand T Irinopoulou E Daugas SA Susin D Cointe ZH Xie JC Reed BP Roques G Kroemer, The Journal of experimental medicine 2000 191 33 46 10.1084/jem.191.1.33 10620603
83. Integration of Metabolism, Energetics, and Signal Transduction. RK Ockner, Springer 2004 chapter 13
84. Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type? S Hoyer K Oesterreich O Wagner, J Neurol 1988 235 143 148 10.1007/BF00314304 3367161
85. Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage. M Manczak BS Park Y Jung PH Reddy, Neuromolecular medicine 2004 5 147 162 10.1385/NMM:5:2:147 15075441
86. Mitochondrial oxidative phosphorylation defects in Parkinson's disease. DC Wallace JM Shoffner RL Watts JL Juncos A Torroni, Annals of neurology 1992 32 113 114 10.1002/ana.410320123 1642467
87. Mitochondria and HIV infection: the first decade. A Cossarizza L Troiano C Mussini, Journal of biological regulators and homeostatic agents 2002 16 18 24 12003168
88. Neuronal glycolytic pathway impairment induced by HIV envelope glycoprotein gp120. AL Vignoli I Martini KG Haglid L Silvestroni G Augusti-Tocco S Biagioni, Molecular and cellular biochemistry 2000 215 73 80 10.1023/A:1026590916661 11204458
89. Reduction of cerebral glucose utilization by the HIV envelope glycoprotein Gp-120. AS Kimes ED London G Szabo L Raymon B Tabakoff, Experimental neurology 1991 112 224 228 10.1016/0014-4886(91)90073-L 2037031
90. HIV-1 p17 and IFN-gamma both induce fructose 1,6-bisphosphatase. F Besancon J Just MF Bourgeade J Van Weyenbergh D Solomon H Guillozo J Wietzerbin YE Cayre, J Interferon Cytokine Res 1997 17 461 467 10.1089/jir.1997.17.461 9282826
91. Mitochondrial complex I activity is impaired during HIV-1-induced T-cell apoptosis. JS Ladha MK Tripathy D Mitra, Cell death and differentiation 2005 12 1417 1428 10.1038/sj.cdd.4401668 15905875
92. Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease? K Honjo R van Reekum NP Verhoeff, Alzheimers Dement 2009 5 348 360 10.1016/j.jalz.2008.12.001 19560105
93. Herpes simplex virus type 1 in Alzheimer's disease: the enemy within. RF Itzhaki MA Wozniak, J Alzheimers Dis 2008 13 393 405 18487848
94. Pathogens as a cause of Alzheimer's disease. J Kinoshita, Neurobiology of aging 2004 25 639 640 10.1016/j.neurobiolaging.2004.02.007 15172742
95. Dementia with features of Alzheimer's disease and HIV-associated dementia in an elderly man with AIDS. KM Brousseau CM Filley K Kaye JJ Kiser LE Adler E Connick, AIDS (London, England) 2009 23 1029 1031 19414994
96. Alzheimer's disease and HIV associated dementia related genes: I. location and function. P Shapshak HE Rodriguez R Kayathri A Levine F Chiappelli A Minagar, Bioinformation 2008 2 348 357 18685724
97. Glutamate metabolizing enzymes in prefrontal cortex of Alzheimer's disease patients. G Burbaeva IS Boksha EB Tereshkina OK Savushkina LI Starodubtseva MS Turishcheva, Neurochemical research 2005 30 1443 1451 10.1007/s11064-005-8654-x 16341942
98. Medial frontal cortex: from self-generated action to reflection on one's own performance. RE Passingham SL Bengtsson HC Lau, Trends in cognitive sciences 2010 14 16 21 10.1016/j.tics.2009.11.001 19969501
99. Evidence for predilection of macrophage infiltration patterns in the deeper midline and mesial temporal structures of the brain uniquely in patients with HIV-associated dementia. L Zhou R Rua T Ng V Vongrad YS Ho C Geczy K Hsu BJ Brew NK Saksena, BMC infectious diseases 2009 9 192 10.1186/1471-2334-9-192 19951441
100. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. NL Johnston-Wilson CD Sims JP Hofmann L Anderson AD Shore EF Torrey RH Yolken, Mol Psychiatry 2000 5 142 149 10.1038/sj.mp.4000696 10822341
101. Functional aspects of cellular microcompartmentation in the development of neurodegeneration: mutation induced aberrant protein-protein associations. J Ovadi F Orosz S Hollan, Molecular and cellular biochemistry 2004 256-257 83 93 10.1023/B:MCBI.0000009860.86969.72 14977172
102. Proteomics analysis of the Alzheimer's disease hippocampal proteome. R Sultana D Boyd-Kimball J Cai WM Pierce JB Klein M Merchant DA Butterfield, J Alzheimers Dis 2007 11 153 164 17522440
103. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. WS Sly D Hewett-Emmett MP Whyte YS Yu RE Tashian, Proceedings of the National Academy of Sciences of the United States of America 1983 80 2752 2756 10.1073/pnas.80.9.2752 6405388
104. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. R Sultana D Boyd-Kimball HF Poon J Cai WM Pierce JB Klein M Merchant WR Markesbery DA Butterfield, Neurobiology of aging 2006 27 1564 1576 10.1016/j.neurobiolaging.2005.09.021 16271804
105. Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down syndrome and Alzheimer's disease. B Balcz L Kirchner N Cairns M Fountoulakis G Lubec, Journal of neural transmission 2001 193 201 11771743
106. Human brain nucleoside diphosphate kinase activity is decreased in Alzheimer's disease and Down syndrome. SH Kim M Fountoulakis NJ Cairns G Lubec, Biochemical and biophysical research communications 2002 296 970 975 10.1016/S0006-291X(02)02035-1 12200143
107. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. MA Lovell C Xie WR Markesbery, Neurology 1998 51 1562 1566 9855502
108. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. A Menegon PG Board AC Blackburn GD Mellick DG Le Couteur, Lancet 1998 352 1344 1346 10.1016/S0140-6736(98)03453-9 9802272
109. Neurofibrillary tangle-associated alteration of stathmin in Alzheimer's disease. LW Jin E Masliah D Iimoto R Deteresa M Mallory M Sundsmo N Mori A Sobel T Saitoh, Neurobiology of aging 1996 17 331 341 10.1016/0197-4580(96)00021-8 8725893
110. Growth factor receptor-bound protein 2 interaction with the tyrosine-phosphorylated tail of amyloid beta precursor protein is mediated by its Src homology 2 domain. D Zhou C Noviello C D'Ambrosio A Scaloni L D'Adamio, The Journal of biological chemistry 2004 279 25374 25380 10.1074/jbc.M400488200 15054097
111. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. H Shimura N Hattori S Kubo Y Mizuno S Asakawa S Minoshima N Shimizu K Iwai T Chiba K Tanaka T Suzuki, Nature genetics 2000 25 302 305 10.1038/77060 10888878
112. Proteomics in animal models of Alzheimer's and Parkinson's diseases. RA Sowell JB Owen DA Butterfield, Ageing research reviews 2009 8 1 17 10.1016/j.arr.2008.07.003 18703168
113. Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain. MA Lovell C Xie SP Gabbita WR Markesbery, Free radical biology & medicine 2000 28 418 427 (Pubitemid 30110658)